WILLIAM MERRITT: Open Payments
NPI 1033442538 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 10 payments from 6 companies in 2025. Trend: 2023 $58 · 2024 $177 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $58 |
| PFIZER INC. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Lilly USA, LLC | 1 | $15 |
Products named: CAPLYTA, REXULTI, PREVNAR 20, Wegovy, AIRSUPRA, ELIQUIS, MOUNJARO.
Industry payments across WI — which companies pay providers there.
